Selective Gastric Cancer Patients with Peritoneal Seeding Benefit from Gastrectomy after Palliative Chemotherapy: A Propensity Score Matching Analysis
Authors:
Open Access
- 1 January 2017
- journal article
- research article
- Published by Ivyspring International Publisher in Journal of Cancer
- Vol. 8 (12) , 2231-2237
Abstract
Background: The present study aimed to explore whether gastric cancer patients with peritoneal seeding after receiving palliative chemotherapy could benefit from gastrectomy and to identify patients with peritoneal seeding who should be selected to receive gastrectomy.Keywords
This publication has 29 references indexed in Scilit:
- Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trialThe Lancet Oncology, 2016
- Hyperthermic intraperitoneal chemotherapy plus simultaneous versus staged cytoreductive surgery for gastric cancer with occult peritoneal metastasisJournal of Surgical Oncology, 2015
- The Clinical Value of Non‐curative Resection Followed by Chemotherapy for Incurable Gastric CancerWorld Journal of Surgery, 2012
- Gastrectomy as a secondary surgery for stage IV gastric cancer patients who underwent S-1-based chemotherapy: a multi-institute retrospective studyGastric Cancer, 2011
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical TrialAnnals of Surgical Oncology, 2011
- Predictive Factors Improving Survival After Gastrectomy in Gastric Cancer Patients with Peritoneal CarcinomatosisWorld Journal of Surgery, 2010
- Salvage Gastrectomy Following a Combination of Biweekly Paclitaxel and S-1 for Stage IV Gastric CancerJournal of Gastrointestinal Surgery, 2008
- Value of palliative resection in gastric cancerBritish Journal of Surgery, 2002
- Complete Response of Highly Advanced Gastric Cancer with Peritoneal Dissemination after New Combined Chemotherapy of S-1 and Low-Dose Cisplatin: Report of a CaseOncology, 2001
- Invited Commentary: Propensity ScoresAmerican Journal of Epidemiology, 1999